Leukocytic endogenous mediator in Crohn's disease

Area of Science:

• Gastroenterology and Immunology
• Nutritional Biochemistry

Background:

• Crohn's disease is associated with inflammatory processes.
• Nutritional deficiencies, including zinc, are common in Crohn's disease patients.
• Leukocytic endogenous mediator (LEM) activity is linked to inflammation and infection.

Purpose of the Study:

• To investigate plasma zinc concentrations and LEM activity in patients with Crohn's disease.
• To differentiate between active exacerbation and quiescent disease states.
• To assess the reliability of plasma zinc as an indicator of zinc status during active Crohn's disease.

Main Methods:

• Measured plasma zinc levels in hospitalized patients with acute Crohn's disease exacerbation and outpatients with quiescent disease.
• Assessed serum leukocytic endogenous mediator (LEM) activity in the same patient groups.
• Compared findings between patients with active disease and those in remission.

Main Results:

• Patients hospitalized with acute Crohn's disease exacerbation showed significantly reduced plasma zinc concentrations.
• Elevated serum LEM activity was observed in patients with active Crohn's disease exacerbation.
• No significant changes in plasma zinc or LEM activity were found in patients with quiescent Crohn's disease.

Conclusions:

• Acute exacerbation of Crohn's disease is characterized by decreased plasma zinc and increased LEM activity.
• LEM activity may be elevated in inflammatory conditions like Crohn's disease.
• Plasma zinc levels alone may be an unreliable indicator of zinc nutritional status in active Crohn's disease.